ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling

Muhong Guo1, Ge Ma2, Xiaolan Zhang3

  • 1Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Aging
|July 3, 2020
PubMed

Insights

Receptor tyrosine kinase-like orphan receptor 2 (ROR2) drives breast cancer progression by promoting cell proliferation and reducing survival. Targeting ROR2 may offer a new therapeutic strategy for breast cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is implicated in various cancers.
  • Its role in breast cancer (BC) progression requires further elucidation.

Purpose of the Study:

  • To investigate the clinical significance of ROR2 in breast cancer (BC) progression.
  • To determine the functional role of ROR2 in BC cell proliferation, growth, and tumorigenesis.

Main Methods:

  • Analysis of ROR2 mRNA levels in BC tissues and adjacent non-tumor tissues.
  • Kaplan-Meier disease-free survival (DFS) analysis.
  • In vitro cell proliferation and apoptosis assays.
  • In vivo mouse BC xenograft models.
  • Investigation of the PI3K/AKT signaling pathway.

Main Results:

  • ROR2 expression was significantly elevated in BC tissues and correlated with tumor diameter.
  • Higher ROR2 expression was associated with lower DFS in BC patients.
  • ROR2 knockdown suppressed BC cell proliferation and induced apoptosis, while ROR2 overexpression had opposite effects.
  • ROR2 suppression reduced tumor growth in vivo.
  • ROR2 promotes BC cell proliferation by activating the PI3K/AKT pathway.

Conclusions:

  • ROR2 functions as an oncogenic gene in breast cancer.
  • The ROR2/PI3K/AKT regulatory network is crucial for BC progression.
  • ROR2 represents a potential therapeutic target for breast cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K